Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/4mw8-0v91

poster

2022 AMA Research Challenge

October 21, 2022

Virtual, United States

Achyrocline B (3,5 dihydroxy-7-methoxyflavone) synergizes with 5-fluorouracil (5-Fu) allowing for 5-Fu dose reduction and reduced off-target toxicity in the treatment of colonic and pancreatic cancers

Please log in to leave a comment

Next from 2022 AMA Research Challenge

Analysis of Glycan Expression in Malignant versus Adjacent Benign Tissue in Breast Cancer Patients
poster

Analysis of Glycan Expression in Malignant versus Adjacent Benign Tissue in Breast Cancer Patients

2022 AMA Research Challenge

Alex Kesic
Alex Kesic

21 October 2022

Similar lecture

N-MYC Transcription Factor Increases the Expression of Alpha-7 Nicotinic Acetylcholine Receptor Promoting Cell Viability in Neuroblastoma Cell Line
poster

N-MYC Transcription Factor Increases the Expression of Alpha-7 Nicotinic Acetylcholine Receptor Promoting Cell Viability in Neuroblastoma Cell Line

2022 AMA Research Challenge

Ledia Tarabey
Ledia Tarabey

21 October 2022